Literature DB >> 9299660

Self-medication of dyspepsia: how appropriate is it?

S Sihvo1, E Hemminki.   

Abstract

BACKGROUND: The scope of self-medication is increasing in many countries, and drugs for dyspepsia are a popular group for deregulative activities. This study investigated what kind of upper gastrointestinal symptoms people self-medicate and how appropriate this self-medication is.
METHODS: An anonymous questionnaire was give to 50 consecutive customers buying antacids, alginates, or sucralfates in 10 pharmacies in the capital area in Finland in 1995. In half of the pharmacies the questionnaire was returned by mail, and in the other half the questionnaire was filled out at the pharmacy. The response rate was 53% (n = 292).
RESULTS: The commonest reasons for self-medication were heartburn (88%), gastrointestinal pain (31%), and acid regurgitation (32%). Seventy-five per cent of respondents had used dyspepsia drugs for more than a year. The commonest way to self-medicate was to interchange regular and occasional use. Knowledge about the proper use of dyspepsia drugs was poor, and 6% of respondents had symptoms contraindicating self-medication but had not visited a physician during the past year. Patients more than 60 years old were especially at risk of potential inappropriate use.
CONCLUSIONS: Over-the-counter (OTC) drugs for dyspepsia are likely to be used improperly. A physician's advice on the use of OTC dyspepsia drugs, in addition to detailed printed information about drug action and proper administration, would be important means to guarantee appropriate use of these drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299660     DOI: 10.3109/00365529709011191

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  Drug utilization evaluation of nonprescription H2-receptor antagonists and alginate-containing preparations for dyspepsia.

Authors:  J Krska; D N John; D Hansford; E J Kennedy
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 2.  Benefits and risks of self medication.

Authors:  C M Hughes; J C McElnay; G F Fleming
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Referrals of dyspeptic self-care patients from pharmacies to physicians, supported by clinical guidelines.

Authors:  Bertil Marklund; Tommy Westerlund; Jan-Olof Brånstad; Magnus Sjöblom
Journal:  Pharm World Sci       Date:  2003-08

4.  Hormonal contraceptive users' self-reported benefits, adverse reactions, and fears in 2001 and 2007.

Authors:  Miia Tiihonen; Hanna-Mari Leppänen; Anna-Mari Heikkinen; Riitta Ahonen
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

5.  Switching of H(2)-Receptor Antagonists to Over-the-Counter Status in Finland : Implications for Consumption and Adverse Effects.

Authors:  Ulla Närhi; Jyrki Vanakoski; Sinikka Sihvo
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Usage patterns of over-the-counter phenazopyridine (pyridium).

Authors:  Chih-Wen Shi; Steven M Asch; Eve Fielder; Lillian Gelberg; Robert H Brook; Barbara Leake; Martin F Shapiro; Patrick Dowling; Michael Nichol
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

7.  Do Finnish women using hormone replacement therapy need more information about risks.

Authors:  Miia J Tiihonen; Anna-Mari Heikkinen; Riitta S Ahonen
Journal:  Pharm World Sci       Date:  2007-04-12

8.  Evaluation of the acid-neutralizing capacity and other properties of antacids marketed in Morocco.

Authors:  Mohamed Yafout; Hicham Elhorr; Ibrahim Sbai El Otmani; Youssef Khayati
Journal:  Med Pharm Rep       Date:  2022-01-31

9.  Information sources used by women in Finland who use hormonal contraceptives.

Authors:  Miia Tiihonen; Anna-Mari Heikkinen; Hanna-Mari Leppänen; Riitta Ahonen
Journal:  Pharm World Sci       Date:  2009-10-30

10.  Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?

Authors:  Ramin Niknam; Sarah Mousavi; Alireza Safarpour; Laleh Mahmoudi; Paria Mahmoudi
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.